Longevity & cellularInjectable

MOTS-c

Also known as: Mitochondrial ORF of the 12S rRNA type-c

MOTS-c is a mitochondrial-derived peptide studied for its possible role in metabolism, insulin sensitivity and cellular energy regulation.

Physician-reviewedDr. Bushra Mir, Medical Director · DHA-licensedReviewed 10 July 2026

The molecule, up close

Class: Mitochondrial-derived peptide
Origin: Encoded within mitochondrial DNA (12S rRNA region)
Chemistry: Small peptide (about 16 amino acids)
Typical format: Injectable
Regulatory status: Prescription-only; not permitted in competitive sport

This page is educational information, not medical advice or an offer of treatment. Peptides used clinically are prescription medicines; whether any is appropriate for you is a decision a physician makes after a diagnostic assessment.

What it is

MOTS-c is another mitochondrial-derived peptide — a short peptide encoded within mitochondrial DNA — that has drawn interest because it appears to act as a metabolic signal, linking the mitochondria to how the whole body handles energy.

It's scientifically interesting and clinically early: a molecule researchers are using to understand metabolism, not yet an established treatment.

What it's studied for

Interest centres on metabolic signalling, insulin sensitivity and exercise-related pathways. In the lab it's studied in models of metabolic health and ageing.

These are areas of study. Metabolic health starts with a proper assessment — where a physician looks at the whole picture and decides whether anything like this has a place alongside established, evidence-based care.

The science

Research links MOTS-c to AMPK, a cellular energy-sensing pathway that helps regulate how cells use glucose and respond to metabolic stress. Some work describes it moving to the cell nucleus under stress to influence gene activity.

The mechanism is an active area of study, and its clinical relevance in people isn't yet established.

Typical form

Injectable

Shown in the dispensing format most often used in research and clinical settings. Where any protocol is appropriate, the route, dose and schedule are a physician’s decision — not a fixed recipe.

Safety & considerations

Still under study and physician-supervised where used. A proper metabolic assessment comes first — diet, activity, established medicine and, where it's genuinely relevant, something like this, weighed together by a physician.

Product sourcing and clinical oversight are central to any responsible use of a research peptide.

Status & oversight

MOTS-c is a research peptide used under physician supervision, and is prohibited in competitive sport under anti-doping rules.

Common questions

MOTS-c, in brief.

What is MOTS-c studied for?

It's studied for metabolism, insulin sensitivity and cellular energy. This is early research rather than an established metabolic treatment.

Is MOTS-c allowed in sport?

No. It's prohibited under World Anti-Doping Agency rules, so competitive athletes should not use it.

Can MOTS-c help with weight or blood sugar?

There isn't yet reliable human evidence to support that. It's studied for metabolic signalling — so metabolic concerns are worth a proper assessment, where a physician can weigh it honestly against established options.

Peptides of this kind are prescription medicines. Whether any protocol is appropriate is decided the way the rest of the practice works — from data, after an assessment.

How our longevity assessment works Back to the peptide field guide

How this is written

Physician-reviewed and evidence-led. We describe what a compound is studied for and where the evidence stands — not what it will do for you — and we revise pages as the science changes. Reviewed by Dr. Bushra Mir, Medical Director · DHA-licensed.

References

Peer-reviewed references for this compound are added by the physician author before publication.